Henry R. Kranzler

Henry R. Kranzler's AcademicInfluence.com Rankings

Henry R. Kranzler

Biology

#4882

World Rank

#7223

Historical Rank

Anatomy

#24

World Rank

#145

Historical Rank

Genetics

#423

World Rank

#489

Historical Rank

Neuroscience

#534

World Rank

#554

Historical Rank

biology Degrees

Download Badge

Biology

Henry R. Kranzler's Degrees

Masters Psychiatry Stanford University

Why Is Henry R. Kranzler Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Henry R. Kranzler's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder (2018) (1248)
The Alcohol Use Disorders Identification Test (AUDIT): validation of a screening instrument for use in medical settings. (1995) (1148)
Genomic Relationships, Novel Loci, and Pleiotropic Mechanisms across Eight Psychiatric Disorders (2019) (724)
Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial. (2005) (540)
A Functional Polymorphism of the μ-Opioid Receptor Gene is Associated with Naltrexone Response in Alcohol-Dependent Patients (2003) (523)
Topiramate for treating alcohol dependence: a randomized controlled trial. (2007) (517)
Opioid-, cannabis- and alcohol-dependent women show more rapid progression to substance abuse treatment. (2004) (490)
Serotonin transporter protein (SLC6A4) allele and haplotype frequencies and linkage disequilibria in African- and European-American and Japanese populations and in alcohol-dependent subjects (1997) (446)
Give them prizes, and they will come: contingency management for treatment of alcohol dependence. (2000) (440)
Alcohol treatment utilization: findings from the National Epidemiologic Survey on Alcohol and Related Conditions. (2007) (434)
Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis. (2001) (397)
Trans-ancestral GWAS of alcohol dependence reveals common genetic underpinnings with psychiatric disorders (2018) (372)
Genome-wide association study of alcohol dependence:significant findings in African- and European-Americans including novel risk loci (2014) (342)
A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. (2003) (330)
Largest GWAS of PTSD (N=20 070) yields genetic overlap with schizophrenia and sex differences in heritability (2017) (328)
Interaction of FKBP5 with Childhood Adversity on Risk for Post-Traumatic Stress Disorder (2010) (318)
Diagnosis and Pharmacotherapy of Alcohol Use Disorder: A Review (2018) (310)
A prospective cohort study investigating factors associated with depression during medical internship. (2010) (301)
Meta‐analysis of the association of a functional serotonin transporter promoter polymorphism with alcohol dependence (2005) (300)
No association between an allele at the D2 dopamine receptor gene (DRD2) and alcoholism. (1991) (285)
Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics. (1995) (278)
Allelic and haplotypic association of GABRA2 with alcohol dependence (2004) (277)
Genome-wide association study of alcohol consumption and use disorder in 274,424 individuals from multiple populations (2019) (259)
International meta-analysis of PTSD genome-wide association studies identifies sex- and ancestry-specific genetic risk loci (2019) (258)
Genetics of two μ opioid receptor gene (OPRM1) exon I polymorphisms: population studies, and allele frequencies in alcohol- and drug-dependent subjects (1999) (257)
Serotonergic and noradrenergic dysregulation in alcoholism: m-chlorophenylpiperazine and yohimbine effects in recently detoxified alcoholics and healthy comparison subjects. (1996) (246)
Genome-wide association study of over 40,000 bipolar disorder cases provides new insights into the underlying biology (2021) (240)
Interactive effect of stressful life events and the serotonin transporter 5-HTTLPR genotype on posttraumatic stress disorder diagnosis in 2 independent populations. (2009) (238)
Early detection of harmful alcohol consumption: comparison of clinical, laboratory, and self-report screening procedures. (1989) (235)
Validity of the SCID in substance abuse patients. (1996) (232)
Buspirone treatment of anxious alcoholics. A placebo-controlled trial. (1994) (230)
Discovery of the first genome-wide significant risk loci for ADHD (2017) (229)
Adverse childhood events as risk factors for substance dependence: partial mediation by mood and anxiety disorders. (2010) (220)
Sertraline treatment for alcohol dependence: interactive effects of medication and alcoholic subtype. (2000) (215)
CHRM2 gene predisposes to alcohol dependence, drug dependence and affective disorders: results from an extended case-control structured association study. (2005) (211)
Fluoxetine treatment seems to reduce the beneficial effects of cognitive-behavioral therapy in type B alcoholics. (1996) (206)
Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative Study. (2007) (205)
Naltrexone vs. Nefazodone for Treatment of Alcohol Dependence: A Placebo-Controlled Trial (2000) (201)
Alcohol and opioid dependence medications: prescription trends, overall and by physician specialty. (2009) (198)
Correlates of co-occurring ADHD in drug-dependent subjects: prevalence and features of substance dependence and psychiatric disorders. (2008) (196)
Comorbid psychiatric diagnosis predicts three-year outcomes in alcoholics: a posttreatment natural history study. (1996) (196)
Association of an Asn40Asp (A118G) polymorphism in the mu-opioid receptor gene with substance dependence: a meta-analysis. (2006) (194)
Self-reports by alcohol and drug abuse inpatients: factors affecting reliability and validity. (1992) (194)
Levels and patterns of alcohol consumption using timeline follow-back, daily diaries and real-time "electronic interviews". (1998) (193)
Brain derived neurotrophic factor (BDNF) gene variants and Alzheimer's disease, affective disorders, posttraumatic stress disorder, schizophrenia, and substance dependence (2006) (189)
No structural mutation in the dopamine D2 receptor gene in alcoholism or schizophrenia. Analysis using denaturing gradient gel electrophoresis. (1994) (187)
Personality, temperament, and character dimensions and the DSM-IV personality disorders in substance abusers. (1997) (186)
Interactive Effects of the Serotonin Transporter 5-HTTLPR Polymorphism and Stressful Life Events on College Student Drinking and Drug Use (2007) (182)
D4 dopamine-receptor (DRD4) alleles and novelty seeking in substance-dependent, personality-disorder, and control subjects. (1997) (182)
Diagnostic reliability of the Semi-structured Assessment for Drug Dependence and Alcoholism (SSADDA). (2005) (181)
A haplotype at the DBH locus, associated with low plasma dopamine β-hydroxylase activity, also associates with cocaine-induced paranoia (2000) (179)
Association Between Alcoholism and γ‐Amino Butyric Acid α2 Receptor Subtype in a Russian Population (2005) (178)
Personality disorders in substance abusers: relation to substance use. (1998) (170)
A functional neuropeptide Y Leu7Pro polymorphism associated with alcohol dependence in a large population sample from the United States. (2002) (166)
Serotonin transporter protein gene polymorphism and personality measures in African American and European American subjects. (1998) (166)
Topiramate treatment for heavy drinkers: moderation by a GRIK1 polymorphism. (2014) (165)
Genome-Wide Association Study of Opioid Dependence: Multiple Associations Mapped to Calcium and Potassium Pathways (2014) (165)
Haplotype spanning TTC12 and ANKK1, flanked by the DRD2 and NCAM1 loci, is strongly associated to nicotine dependence in two distinct American populations. (2006) (162)
Association between two mu-opioid receptor gene (OPRM1) haplotype blocks and drug or alcohol dependence. (2006) (160)
The OPRD1 and OPRK1 loci in alcohol or drug dependence: OPRD1 variation modulates substance dependence risk (2008) (157)
Genomewide association study of cocaine dependence and related traits: FAM53B identified as a risk gene (2013) (157)
Genome-Wide Association Studies of a Broad Spectrum of Antisocial Behavior (2017) (155)
Effects of the 2011 duty hour reforms on interns and their patients: a prospective longitudinal cohort study. (2013) (153)
Naltrexone depot for treatment of alcohol dependence: a multicenter, randomized, placebo-controlled clinical trial. (2004) (153)
Genome-wide Association Study Identifies New Susceptibility Loci for Posttraumatic Stress Disorder (2013) (152)
Genome-wide meta-analysis of problematic alcohol use in 435,563 individuals yields insights into biology and relationships with other traits (2020) (150)
Association between the cortisol response to opioid blockade and the Asn40Asp polymorphism at the μ‐opioid receptor locus (OPRM1) (2003) (147)
A common polymorphism in serotonin receptor 1B mRNA moderates regulation by miR-96 and associates with aggressive human behaviors (2009) (146)
GABRA2 Alleles Moderate the Subjective Effects of Alcohol, Which are Attenuated by Finasteride (2005) (143)
Genome-wide Association Study of Cannabis Dependence Severity, Novel Risk Variants, and Shared Genetic Risks. (2016) (141)
Effects of gender and family history of alcohol dependence on a behavioral task of impulsivity in healthy subjects. (2002) (136)
What Is Addiction? (2019) (136)
A Genetic Investigation of Sex Bias in the Prevalence of Attention-Deficit/Hyperactivity Disorder (2017) (136)
Genome-wide association study of lifetime cannabis use based on a large meta-analytic sample of 32 330 subjects from the International Cannabis Consortium (2016) (134)
Serotonin Transporter Gene Polymorphism (5-HTTLPR) and Anxiety Reactivity in Daily Life: A Daily Process Approach to Gene-Environment Interaction (2007) (132)
Genomewide linkage scan for cocaine dependence and related traits: Significant linkages for a cocaine‐related trait and cocaine‐induced paranoia (2005) (129)
Genomewide linkage scan for opioid dependence and related traits. (2006) (127)
Nicotine Gum for Pregnant Smokers: A Randomized Controlled Trial (2008) (126)
Association between alcoholism and gamma-amino butyric acid alpha2 receptor subtype in a Russian population. (2005) (125)
Sustained-release naltrexone for alcoholism treatment: a preliminary study. (1998) (125)
Association of haplotypic variants in DRD2, ANKK1, TTC12 and NCAM1 to alcohol dependence in independent case control and family samples. (2007) (125)
Reliability of DSM-IV diagnostic criteria using the semi-structured assessment for drug dependence and alcoholism (SSADDA). (2007) (125)
Double-Blind Clinical Trial of Sertraline Treatment for Alcohol Dependence (2001) (124)
Utility of the AUDIT for identification of hazardous or harmful drinking in drug-dependent patients. (1997) (123)
A Multi-site Dose Ranging Study of Nalmefene in the Treatment of Alcohol Dependence (2004) (121)
Variation in Nicotinic Acetylcholine Receptor Genes is Associated with Multiple Substance Dependence Phenotypes (2010) (119)
Practical population group assignment with selected informative markers: Characteristics and properties of Bayesian clustering via STRUCTURE (2005) (118)
Understanding US addiction physicians' low rate of naltrexone prescription. (2003) (118)
Pharmacotherapy of alcohol use disorders: seventy-five years of progress. (2014) (118)
Population genetics of a functional variant of the dopamine beta-hydroxylase gene (DBH). (1997) (116)
Diplotype trend regression analysis of the ADH gene cluster and the ALDH2 gene: multiple significant associations with alcohol dependence. (2006) (113)
Haplotypes at the OPRM1 locus are associated with susceptibility to substance dependence in European‐Americans (2003) (112)
Physicians' opinions about medications to treat alcoholism. (2003) (112)
Effects of ondansetron in early- versus late-onset alcoholics: a prospective, open-label study. (2003) (112)
Efficacy of Extended-Release Naltrexone in Alcohol-Dependent Patients Who Are Abstinent Before Treatment (2007) (112)
Improvement of physical health and quality of life of alcohol-dependent individuals with topiramate treatment: US multisite randomized controlled trial. (2008) (110)
Pharmacotherapy of alcoholism: gaps in knowledge and opportunities for research. (2000) (110)
A Randomized, Multicenter, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Aripiprazole for the Treatment of Alcohol Dependence (2008) (110)
CNR1 Variation Modulates Risk for Drug and Alcohol Dependence (2007) (109)
Clinical Validation of Reduced Alcohol Consumption After Treatment for Alcohol Dependence Using the World Health Organization Risk Drinking Levels (2016) (107)
ADH4 Gene Variation is Associated with Alcohol Dependence and Drug Dependence in European Americans: Results from HWD Tests and Case–Control Association Studies (2006) (107)
Genetic Association between Dopamine Transporter Protein Alleles and Cocaine-Induced Paranoia (1995) (105)
A large-scale genome-wide association study meta-analysis of cannabis use disorder (2020) (104)
A large-scale genome-wide association study meta-analysis of cannabis use disorder (2020) (104)
ALDH2 is associated to alcohol dependence and is the major genetic determinant of “daily maximum drinks” in a GWAS study of an isolated rural chinese sample (2014) (103)
The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Substance Use and Related Disorders. Part 2: Opioid dependence (2011) (103)
Barriers to the use of medications to treat alcoholism. (2001) (102)
Prevalence of DSM-IV and DSM-5 alcohol, cocaine, opioid, and cannabis use disorders in a largely substance dependent sample. (2013) (101)
Haplotypic variants in DRD2, ANKK1, TTC12, and NCAM1 are associated with comorbid alcohol and drug dependence. (2008) (100)
Alcohol Dependence Genetics: Lessons Learned From Genome-Wide Association Studies (GWAS) and Post-GWAS Analyses. (2015) (100)
Validity of psychiatric diagnoses in patients with substance use disorders: is the interview more important than the interviewer? (1995) (100)
Genome-wide association study across European and African American ancestries identifies a SNP in DNMT3B contributing to nicotine dependence (2017) (100)
Assessment of medication compliance in alcoholics through UV light detection of a riboflavin tracer. (1996) (99)
Evidence of CNIH3 involvement in opioid dependence (2015) (96)
Meta‐Analysis of the Association of Alcohol‐Related Social Media Use with Alcohol Consumption and Alcohol‐Related Problems in Adolescents and Young Adults (2018) (96)
Reliability of personality disorder symptoms and personality traits in substance-dependent inpatients. (2001) (96)
Cross system agreement for substance use disorders: DSM-III-R, DSM-IV and ICD-10. (1993) (95)
Specificity of ethanollike effects elicited by serotonergic and noradrenergic mechanisms. (1994) (94)
Genetic Association between Dopamine Transporter Protein Alleles and Cocaine-Induced Paranoia (1994) (94)
Association of the OPRM1 Variant rs1799971 (A118G) with Non-Specific Liability to Substance Dependence in a Collaborative de novo Meta-Analysis of European-Ancestry Cohorts (2016) (94)
Psychometric properties of the short index of problems as a measure of recent alcohol-related problems. (2003) (92)
ADH4 gene variation is associated with alcohol and drug dependence: results from family controlled and population-structured association studies (2005) (92)
Targeted Naltrexone for Early Problem Drinkers (2003) (90)
Naltrexone treatment of comorbid alcohol and cocaine use disorders (1998) (90)
Sertraline Treatment of Co-occurring Alcohol Dependence and Major Depression (2006) (89)
Axis I and Axis II disorders in alcoholics and drug addicts: fact or artifact? (2000) (89)
A randomized clinical trial of brief interventions in primary health care: summary of a WHO project (1994) (89)
Does affect mediate the association between daily events and alcohol use? (2000) (88)
Association of OPRM1 Functional Coding Variant With Opioid Use Disorder: A Genome-Wide Association Study. (2020) (88)
Markers in the 5′-Region of GABRG1 Associate to Alcohol Dependence and are in Linkage Disequilibrium with Markers in the Adjacent GABRA2 Gene (2008) (87)
Ritanserin in the treatment of alcohol dependence – a multi-center clinical trial (1996) (87)
Mecamylamine modifies the pharmacokinetics and reinforcing effects of alcohol. (2002) (85)
Array-based profiling of DNA methylation changes associated with alcohol dependence. (2013) (85)
Change in non-abstinent WHO drinking risk levels and alcohol dependence: a 3 year follow-up study in the US general population. (2017) (85)
D2 Dopamine Receptor Gene (DRD2) Allele and Haplotype Frequencies in Alcohol Dependent and Control Subjects: No Association with Phenotype or Severity of Phenotype (1999) (85)
Factor replicability and validity of the Temperament and Character Inventory in substance-dependent patients. (1999) (84)
Dual diagnosis: alcoholism and co-morbid psychiatric disorders. (2003) (83)
A Double-Blind, Randomized Trial of Sertraline for Alcohol Dependence: Moderation by Age of Onset and 5-Hydroxytryptamine Transporter-Linked Promoter Region Genotype (2011) (83)
Functional polymorphisms in the serotonin 1B receptor gene (HTR1B) predict self‐reported anger and hostility among young men (2009) (83)
Adverse effects of oral naltrexone: analysis of data from two clinical trials (2001) (83)
Validity of the Obsessive Compulsive Drinking Scale (OCDS): does craving predict drinking behavior? (1999) (82)
Implications of recent neuropsychopharmacologic research for understanding the etiology and development of alcoholism. (1994) (82)
The validity of self-reported cocaine use in two groups of cocaine abusers. (1999) (81)
Association of Gamma-Aminobutyric Acid A Receptor α2 Gene (GABRA2) with Alcohol Use Disorder (2014) (79)
Population studies of polymorphisms at loci of neuropsychiatric interest (tryptophan hydroxylase (TPH), dopamine transporter protein (SLC6A3), D3 dopamine receptor (DRD3), apolipoprotein E (APOE), mu opioid receptor (OPRM1), and ciliary neurotrophic factor (CNTF)). (1998) (79)
Variation in GABRA2 predicts drinking behavior in project MATCH subjects. (2007) (79)
Social drinking as a health and psychosocial risk factor. Anstie's limit revisited. (1987) (79)
Correlates of Electronic Cigarettes Use Before and During Pregnancy (2017) (78)
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Substance Use and Related Disorders, Part 1: Alcoholism (2008) (78)
Genetic risk prediction and neurobiological understanding of alcoholism (2014) (78)
Targeted Naltrexone for Problem Drinkers (2009) (78)
Dual diagnosis and treatment : substance abuse and comorbid medical and psychiatric disorders (1998) (78)
Genome-wide meta-analysis reveals common splice site acceptor variant in CHRNA4 associated with nicotine dependence (2015) (76)
Genomewide Linkage Scan for Nicotine Dependence: Identification of a Chromosome 5 Risk Locus (2007) (76)
Association of alcohol or other drug dependence with alleles of the mu opioid receptor gene (OPRM1). (1998) (74)
Genome-wide association study of therapeutic opioid dosing identifies a novel locus upstream of OPRM1 (2017) (74)
The pharmacogenetics of alcohol use disorder. (2015) (74)
Targeted versus daily naltrexone: secondary analysis of effects on average daily drinking. (2006) (73)
Genetic associations with suicide attempt severity and genetic overlap with major depression (2019) (73)
Effects of opioid receptor gene variation on targeted nalmefene treatment in heavy drinkers. (2008) (71)
Association study of alcoholism subtypes with a functional promoter polymorphism in the serotonin transporter protein gene. (2002) (70)
Polygenic Scores for Major Depressive Disorder and Risk of Alcohol Dependence (2017) (70)
Association study of the CNR1 gene exon 3 alternative promoter region polymorphisms and substance dependence (2006) (70)
Targeted naltrexone treatment of early problem drinkers. (1997) (69)
Association of psychiatric and substance use disorder comorbidity with cocaine dependence severity and treatment utilization in cocaine-dependent individuals. (2009) (69)
Sweet taste preference as a risk factor for alcohol dependence. (2001) (68)
Serotonin transporter 5‐HTTLPR genotype moderates the effects of childhood adversity on posttraumatic stress disorder risk: A replication study (2012) (67)
Anxiety and depression in substance abuse: clinical implications. (1988) (67)
Dissecting the Shared Genetic Architecture of Suicide Attempt, Psychiatric Disorders, and Known Risk Factors (2020) (66)
Rare Nonsynonymous Variants in Alpha-4 Nicotinic Acetylcholine Receptor Gene Protect Against Nicotine Dependence (2011) (66)
Personality disorder and dimension differences between type A and type B substance abusers. (1998) (66)
Genome-Wide Association Study of Alcohol Dependence Implicates KIAA0040 on Chromosome 1q (2012) (66)
Childhood Adversity Increases Risk for Nicotine Dependence and Interacts with α5 Nicotinic Acetylcholine Receptor Genotype Specifically in Males (2012) (65)
Integrating GWASs and human protein interaction networks identifies a gene subnetwork underlying alcohol dependence. (2013) (65)
Determination of fluoxetine and norfluoxetine by high-performance liquid chromatography. (1990) (65)
Validity of the longitudinal, expert, all data procedure for psychiatric diagnosis in patients with psychoactive substance use disorders. (1997) (65)
Genome-Wide Association Study of Nicotine Dependence in American Populations: Identification of Novel Risk Loci in Both African-Americans and European-Americans (2015) (65)
Effects of Naltrexone on Smoking Cessation Outcomes and Weight Gain in Nicotine-Dependent Men and Women (2012) (64)
Pharmacogenetics of alcohol and alcohol dependence treatment. (2010) (64)
Measurement of admixture proportions and description of admixture structure in different U.S. populations (2009) (64)
Effects of nicotine deprivation on urges to drink and smoke in alcoholic smokers. (2003) (63)
Carbamazepine treatment of cocaine dependence: a placebo-controlled trial. (1995) (63)
Genetic Risk Variants Associated With Comorbid Alcohol Dependence and Major Depression (2017) (63)
Co‐occurrence of Axis I and Axis II disorders in substance abusers (2000) (62)
Neuropsychologic findings in cocaine-dependent outpatients (1998) (62)
Multivariate analysis of 1.5 million people identifies genetic associations with traits related to self-regulation and addiction (2021) (62)
Typologies of drug dependence: comparative validity of a multivariate and four univariate models. (2004) (62)
Bromocriptine and cocaine cue reactivity in cocaine-dependent patients. (1992) (61)
Using daily interactive voice response technology to measure drinking and related behaviors in a pharmacotherapy study. (2004) (60)
Evaluation of Drinking Risk Levels as Outcomes in Alcohol Pharmacotherapy Trials: A Secondary Analysis of 3 Randomized Clinical Trials (2019) (60)
Recommendations for the Design and Analysis of Treatment Trials for Alcohol Use Disorders. (2015) (60)
Risks of alcohol use disorders related to drinking patterns in the U.S. general population. (2014) (60)
Genome-wide Association Study of Maximum Habitual Alcohol Intake in >140,000 U.S. European and African American Veterans Yields Novel Risk Loci (2019) (60)
No association between D2 dopamine receptor (DRD2) alleles or haplotypes and cocaine dependence or severity of cocaine dependence in European- and African-Americans (1999) (60)
Drinking Risk Level Reductions Associated with Improvements in Physical Health and Quality of Life Among Individuals with Alcohol Use Disorder (2018) (60)
Personalized Treatment of Alcohol Dependence (2012) (60)
Population-specific effects of the Asn40Asp polymorphism at the μ-opioid receptor gene (OPRM1) on HPA-axis activation (2007) (59)
Personality disorders and associated features in cocaine-dependent inpatients. (1994) (59)
DRD2 allele frequencies and linkage disequilibria, including the -141CIns/Del promoter polymorphism, in European-American, African-American, and Japanese subjects. (1998) (59)
Association of markers in the 3' region of the GluR5 kainate receptor subunit gene to alcohol dependence. (2009) (58)
Genetic Relationship between Schizophrenia and Nicotine Dependence (2016) (58)
Leveraging genome-wide data to investigate differences between opioid use vs. opioid dependence in 41,176 individuals from the Psychiatric Genomics Consortium (2019) (58)
Genetic Relationship between Schizophrenia and Nicotine Dependence (2016) (58)
A CRHR1 haplotype moderates the effect of adverse childhood experiences on lifetime risk of major depressive episode in African‐American women (2011) (57)
Personality and substance use disorders as predictors of criminality. (2000) (57)
Genomewide Association Study for Maximum Number of Alcoholic Drinks in European Americans and African Americans. (2015) (56)
Prevention, screening, and treatment for heavy drinking and alcohol use disorder. (2019) (56)
Problems associated with average alcohol consumption and frequency of intoxication in a medical population. (1990) (56)
Pharmacotherapies to enhance smoking cessation during pregnancy. (2003) (56)
Rating the severity and character of transient cocaine-induced delusions and hallucinations with a new instrument, the Scale for Assessment of Positive Symptoms for Cocaine-Induced Psychosis (SAPS-CIP). (2005) (55)
Genome-Wide Association Study of Alcohol Dependence Implicates KIAA0040 on Chromosome 1q (2012) (55)
Association of a long‐chain fatty acid‐CoA ligase 4 gene polymorphism with depression and with enhanced niacin‐induced dermal erythema (2004) (54)
Genetics of alcohol dependence (2009) (54)
Hypermethylation of OPRM1 promoter region in European Americans with alcohol dependence (2012) (54)
Polymorphism of the 5-HT1B Receptor Gene (HTR1B): Strong Within-Locus Linkage Disequilibrium without Association to Antisocial Substance Dependence (2002) (54)
GABRA2 markers moderate the subjective effects of alcohol (2013) (54)
Validity of the Distinction Between “Substance‐Induced” and “Independent” Depression and Anxiety Disorders (1995) (54)
Acamprosate efficacy in alcohol-dependent patients: summary of results from three pivotal trials. (2008) (53)
Expanding the genetic architecture of nicotine dependence and its shared genetics with multiple traits (2020) (53)
Genome-wide Association Study Identifies a Regulatory Variant of RGMA Associated With Opioid Dependence in European Americans (2018) (53)
Comorbid psychiatric diagnoses and their association with cocaine-induced psychosis in cocaine-dependent subjects. (2007) (53)
Subjective effects and changes in steroid hormone concentrations in humans following acute consumption of alcohol (2006) (53)
5-HTTLPR as a potential moderator of the effects of adverse childhood experiences on risk of antisocial personality disorder (2011) (52)
Drinking to cope: a comparison of questionnaire and electronic diary reports. (2005) (52)
Electroencephalographic activity and mood in cocaine-dependent outpatients: Effects of cocaine cue exposure (1994) (52)
Topiramate for smoking cessation: a randomized, placebo-controlled pilot study. (2014) (51)
Association study of cannabinoid receptor gene (CNR1) alleles and drug dependence (2001) (51)
Variation in OPRM1 moderates the effect of desire to drink on subsequent drinking and its attenuation by naltrexone treatment (2013) (51)
Effect of extended-release naltrexone (XR-NTX) on quality of life in alcohol-dependent patients. (2009) (50)
Methods to analyze treatment effects in the presence of missing data for a continuous heavy drinking outcome measure when participants drop out from treatment in alcohol clinical trials. (2014) (50)
No association between ADCYAP1R1 and post-traumatic stress disorder in two independent samples (2012) (50)
Reduction of alcohol drinking in young adults by naltrexone: a double-blind, placebo-controlled, randomized clinical trial of efficacy and safety. (2015) (49)
Intronic variants in the dopa decarboxylase (DDC) gene are associated with smoking behavior in European-Americans and African-Americans. (2006) (49)
The Type A/Type B Distinction (1994) (48)
Variation at APOE and STH loci and Alzheimer's disease (2006) (48)
Persistence with oral naltrexone for alcohol treatment: implications for health-care utilization. (2008) (47)
Guidelines for biological treatment of substance use and related disorders, part 1: Alcoholism, first revision (2017) (46)
Nefazodone treatment of comorbid alcohol dependence and major depression. (2004) (46)
Profiling of Childhood Adversity-Associated DNA Methylation Changes in Alcoholic Patients and Healthy Controls (2013) (46)
Effect of Maternal Smoking on Fetal Catecholamine Concentrations at Birth (2003) (46)
Dental pathology and alcohol-related indicators in an outpatient clinic sample. (1990) (46)
Family-based study of DRD2 alleles in alcohol and drug dependence. (2000) (46)
Author Correction: Genome-wide association study of alcohol consumption and use disorder in 274,424 individuals from multiple populations (2019) (45)
Multiple ADH genes modulate risk for drug dependence in both African- and European-Americans. (2007) (45)
A meta-analysis of the efficacy of gabapentin for treating alcohol use disorder. (2019) (45)
Diagnosis and Treatment of Alcohol-Dependent Patients With Comorbid Psychiatric Disorders (1999) (45)
Rate of progression from first use to dependence on cocaine or opioids: a cross-substance examination of associated demographic, psychiatric, and childhood risk factors. (2014) (45)
An open trial of buspirone in alcoholics. (1989) (44)
Generalizability of the type A/type B distinction across different psychoactive substances. (1996) (44)
Elevated rates of early discontinuation from pharmacotherapy trials in alcoholics and drug abusers. (1996) (44)
Dual diagnosis and psychiatric treatment : substance abuse and comorbid disorders (2004) (43)
Risk factors for cocaine-induced paranoia in cocaine-dependent sibling pairs. (2006) (43)
Adrenocorticotropin and cortisol responses to a naloxone challenge and risk of alcoholism (2002) (43)
Treatment of inhalant-induced psychotic disorder with carbamazepine versus haloperidol. (1998) (42)
Alleles of a functional serotonin transporter promoter polymorphism are associated with major depression in alcoholics. (2003) (42)
Improved methods to identify stable, highly heritable subtypes of opioid use and related behaviors. (2012) (41)
DSM-5 gambling disorder: prevalence and characteristics in a substance use disorder sample. (2014) (41)
Oxytocin receptor gene polymorphisms, attachment, and PTSD: Results from the National Health and Resilience in Veterans Study. (2017) (41)
GABRG1 and GABRA2 variation associated with alcohol dependence in African Americans. (2012) (41)
Identification of methylation quantitative trait loci (mQTLs) influencing promoter DNA methylation of alcohol dependence risk genes (2014) (41)
The contribution of genetics to addiction therapy approaches. (2005) (41)
Linkage Analysis Followed by Association Show NRG1 Associated with Cannabis Dependence in African Americans (2012) (41)
Insomnia in alcohol dependent subjects is associated with greater psychosocial problem severity. (2015) (40)
Longitudinal, Expert, All Data Procedure for Psychiatric Diagnosis in Patients with Psychoactive Substance Use Disorders (1994) (40)
Effects of naltrexone on cue-elicited craving for alcohol and cocaine. (1997) (40)
A randomized clinical trial of naltrexone and behavioral therapy for problem drinking men who have sex with men. (2012) (39)
Naltrexone and Brief Counseling to Reduce Heavy Drinking (1994) (39)
Treatment of Co-Occurring Alcohol and Other Drug Use Disorders (2008) (39)
What do we know about the role of pharmacotherapy for smoking cessation before or during pregnancy? (2009) (39)
Targeted naltrexone treatment moderates the relations between mood and drinking behavior among problem drinkers. (2004) (39)
The validity of cocaine dependence subtypes. (2008) (38)
Pro-Opiomelanocortin Gene Variation Related to Alcohol or Drug Dependence: Evidence and Replications Across Family- and Population-based Studies (2009) (38)
Transdermal nicotine for smoking cessation in postmenopausal women. (2007) (38)
Placebo-Controlled Trial of Zonisamide for the Treatment of Alcohol Dependence (2010) (38)
A genome-wide gene-by-trauma interaction study of alcohol misuse in two independent cohorts identifies PRKG1 as a risk locus (2017) (38)
Genomewide Association Study of Alcohol Dependence Identifies Risk Loci Altering Ethanol‐Response Behaviors in Model Organisms (2017) (38)
Genome-Wide Association Study of Copy Number Variations (CNVs) with Opioid Dependence (2015) (37)
Pilot study of iPS-derived neural cells to examine biologic effects of alcohol on human neurons in vitro. (2012) (37)
Variation in genes encoding the neuroactive steroid synthetic enzymes 5α-reductase type 1 and 3α-reductase type 2 is associated with alcohol dependence. (2011) (36)
Cognitive Behavioral Therapy for Insomnia in Alcohol-Dependent Veterans: A Randomized, Controlled Pilot Study. (2019) (36)
Persistent delirium following cessation of heavy alcohol consumption: diagnostic and treatment implications. (1997) (36)
The 5‐HTTLPR polymorphism moderates the effect of stressful life events on drinking behavior in college students of African descent (2012) (36)
Variant detection at the δ opioid receptor (OPRD1) locus and population genetics of a novel variant affecting protein sequence (2000) (36)
Dense Genomewide Linkage Scan for Alcohol Dependence in African Americans: Significant Linkage on Chromosome 10 (2009) (35)
Effects of aripiprazole on subjective and physiological responses to alcohol. (2008) (35)
Genomic influences on self-reported childhood maltreatment (2019) (35)
NOTCH4 gene haplotype is associated with schizophrenia in African Americans (2004) (35)
Interaction between two independent CNR1 variants increases risk for cocaine dependence in European Americans (2008) (35)
GRIK1 genotype moderates topiramate's effects on daily drinking level, expectations of alcohol's positive effects and desire to drink. (2014) (35)
The Interplay Between Risky Sexual Behaviors and Alcohol Dependence: Genome-Wide Association and Neuroimaging Support for LHPP as a Risk Gene (2017) (35)
Genome-wide association study of smoking trajectory and meta-analysis of smoking status in 842,000 individuals (2020) (35)
Genomewide association study identifies a novel locus for cannabis dependence (2017) (34)
A GABRA2 variant is associated with increased stimulation and 'high' following alcohol administration. (2014) (34)
No association between D3 dopamine receptor (DRD3) alleles and cocaine dependence (1996) (34)
Methamphetamine and paranoia: the methamphetamine experience questionnaire. (2010) (34)
A Genomewide Linkage Scan of Cocaine Dependence and Major Depressive Episode in Two Populations (2011) (34)
The Pharmacology of Alcohol Abuse (1995) (33)
Use of buspirone in an adolescent with overanxious disorder. (1988) (33)
Personality Traits of Agreeableness and Extraversion are Associated with ADH4 Variation (2007) (33)
Association of CHRNA4 polymorphisms with smoking behavior in two populations (2011) (33)
Reduction in Nonabstinent WHO Drinking Risk Levels and Change in Risk for Liver Disease and Positive AUDIT‐C Scores: Prospective 3‐Year Follow‐Up Results in the U.S. General Population (2018) (33)
Association between polymorphisms in catechol‐O‐methyltransferase (COMT) and cocaine‐induced paranoia in European‐American and African‐American populations (2011) (32)
Serum prolactin level, craving, and early discharge from treatment in cocaine-dependent patients. (1992) (32)
A functional serotonin transporter gene polymorphism and depressive effects associated with interferon-alpha treatment. (2010) (32)
Multi-view singular value decomposition for disease subtyping and genetic associations (2014) (32)
Functional impact of a single nucleotide polymorphism in the OPRD1 promoter region (2010) (32)
GABRA2 Alcohol Dependence Risk Allele is Associated with Reduced Expression of Chromosome 4p12 GABAA Subunit Genes in Human Neural Cultures. (2015) (32)
Evaluation of a point-of-care testing product for drugs of abuse; testing site is a key variable. (1995) (32)
Pharmacologic treatments for drug and alcohol dependence. (1999) (32)
Adolescent cannabis use increases risk for cocaine-induced paranoia. (2010) (31)
Precision medicine and pharmacogenetics: what does oncology have that addiction medicine does not? (2017) (31)
Post-treatment outcomes in a double-blind, randomized trial of sertraline for alcohol dependence. (2012) (31)
The status of serotonin-selective pharmacotherapy in the treatment of alcohol dependence. (2003) (31)
Concurrent and predictive validity of antisocial personality disorder subtyping among substance abusers. (1999) (30)
Treatment of alcohol dependence. (1997) (30)
Genetic Vulnerability to Menthol Cigarette Preference in Women. (2015) (30)
Varenicline and neuronal nicotinic acetylcholine receptors: a new approach to the treatment of co-occurring alcohol and nicotine addiction? (2013) (30)
Phenome-Wide Association Study for Alcohol and Nicotine Risk Alleles in 26394 Women (2016) (30)
Variation in the gene encoding the serotonin transporter is associated with a measure of sociopathy in alcoholics (2011) (29)
Does effect size in naltrexone trials for alcohol dependence differ for single-site vs. multi-center studies? (2005) (29)
Cognitive Flexibility is Associated with KIBRA Variant and Modulated by Recent Tobacco Use (2009) (29)
An Interpersonal Model of Addiction Relapse (2013) (29)
Characterization of a likelihood based method and effects of markers informativeness in evaluation of admixture and population group assignment (2005) (29)
A putative causal relationship between genetically determined female body shape and posttraumatic stress disorder (2017) (28)
A putative causal relationship between genetically determined female body shape and posttraumatic stress disorder (2017) (28)
Dutasteride reduces alcohol’s sedative effects in men in a human laboratory setting and reduces drinking in the natural environment (2014) (28)
Human clock, PER1 and PER2 polymorphisms: lack of association with cocaine dependence susceptibility and cocaine-induced paranoia (2006) (28)
Genetics of drug dependence (2010) (28)
The Alcohol Clinical Trials Initiative (ACTIVE): Purpose and Goals for Assessing Important and Salient Issues for Medications Development in Alcohol Use Disorders (2012) (28)
M3: an improved SNP calling algorithm for Illumina BeadArray data (2012) (28)
Polygenic risk for alcohol dependence associates with alcohol consumption, cognitive function and social deprivation in a population‐based cohort (2015) (28)
Evaluation and treatment of anxiety symptoms and disorders in alcoholics. (1996) (28)
Carbamazepine and cocaine-cue reactivity. (1995) (28)
Comparing the utility of homogeneous subtypes of cocaine use and related behaviors with DSM‐IV cocaine dependence as traits for genetic association analysis (2014) (27)
Comparison of healthcare utilization among patients treated with alcoholism medications. (2010) (27)
A serotonin transporter gene polymorphism (5-HTTLPR), drinking-to-cope motivation, and negative life events among college students. (2008) (27)
Neurobehavioral aspects of the pharmacotherapy of alcohol dependence. (1995) (27)
Effects of rapid tryptophan depletion on mood and urge to drink in patients with co-morbid major depression and alcohol dependence (2004) (27)
Circadian clock period inversely correlates with illness severity in cells from patients with alcohol use disorders. (2013) (27)
Empirically derived subtypes of opioid use and related behaviors. (2011) (27)
Inter-rater reliability and concurrent validity of DSM-IV opioid dependence in a Hmong isolate using the Thai version of the Semi-Structured Assessment for Drug Dependence and Alcoholism (SSADDA). (2011) (27)
Demographic changes and marker properties affect detection of human population differentiation (2007) (27)
Multiple OPR genes influence personality traits in substance dependent and healthy subjects in two American populations (2008) (27)
Maintenance of World Health Organization Risk Drinking Level Reductions and Posttreatment Functioning Following a Large Alcohol Use Disorder Clinical Trial (2019) (27)
Mutation screen of the GAD2 gene and association study of alcoholism in three populations (2007) (26)
CHRM2 variation predisposes to personality traits of agreeableness and conscientiousness. (2007) (26)
Missing Data in Alcohol Clinical Trials with Binary Outcomes. (2016) (26)
Transient cocaine-associated behavioral symptoms rated with a new instrument, the scale for assessment of positive symptoms for cocaine-induced psychosis (SAPS-CIP). (2009) (26)
FKBP5 genotype interacts with early life trauma to predict heavy drinking in college students (2016) (26)
Comparison of alcoholism subtypes as moderators of the response to sertraline treatment. (2012) (26)
Reduction in non-abstinent WHO drinking risk levels and depression/anxiety disorders: 3-year follow-up results in the US general population. (2019) (26)
The joint effects of ADH1B variants and childhood adversity on alcohol related phenotypes in African-American and European-American women and men. (2014) (26)
Associations between alcohol consumption and gray and white matter volumes in the UK Biobank (2022) (26)
Multivariate genomic analysis of 1.5 million people identifies genes related to addiction, antisocial behavior, and health (2020) (25)
World Health Organization Risk Drinking Level Reductions Are Associated with Improved Functioning and Are Sustained Among Patients with Mild, Moderate, and Severe Alcohol Dependence in Clinical Trials in the United States and United Kingdom. (2020) (25)
Advancing Precision Medicine for Alcohol Use Disorder: Replication and Extension of Reward Drinking as a Predictor of Naltrexone Response (2019) (25)
A multiancestry genome-wide association study of unexplained chronic ALT elevation as a proxy for nonalcoholic fatty liver disease with histological and radiological validation (2021) (25)
Self‐efficacy mediates the effects of topiramate and GRIK1 genotype on drinking (2016) (25)
No association of PROP taster status and paternal history of alcohol dependence. (1996) (25)
Naltrexone and Brief Counseling to Reduce Heavy Drinking: Results of a Small Clinical Trial (1994) (25)
Guidelines for the Reporting of Treatment Trials for Alcohol Use Disorders. (2015) (25)
Evidence-based treatments for alcohol dependence: new results and new questions. (2006) (24)
Screening for health behaviors in ambulatory clinical settings: does smoking status predict hazardous drinking? (2002) (24)
Quantitative real-time PCR for gene dosage determinations in microdeletion genotypes. (2003) (24)
Subtypes of major depression in substance dependence. (2009) (24)
Insomnia in alcohol dependence: predictors of symptoms in a sample of veterans referred from primary care. (2013) (24)
Genomewide Study of Epigenetic Biomarkers of Opioid Dependence in European- American Women (2019) (23)
Rates of personality disorders in substance abusers: a comparison between DSM-III-R and DSM-IV. (1999) (23)
Measurement and prediction of medication compliance in problem drinkers. (2003) (23)
Confirmation and fine mapping of the chromosome 1 alcohol dependence risk locus (2004) (23)
The effects of a MAP2K5 microRNA target site SNP on risk for anxiety and depressive disorders (2014) (23)
Using cue reactivity to evaluate medications for treatment of cocaine dependence: a critical review. (1999) (23)
PROP taster status and parental history of alcohol dependence. (1998) (22)
Substance dependence low-density whole genome association study in two distinct American populations (2008) (22)
Inter-observer reliability of DSM-5 substance use disorders. (2015) (22)
Association of variants in MANEA with cocaine-related behaviors. (2009) (22)
Temporal Stability of Heavy Drinking Days and Drinking Reductions Among Heavy Drinkers in the COMBINE Study (2017) (22)
Largest genome-wide association study for PTSD identifies genetic risk loci in European and African ancestries and implicates novel biological pathways (2018) (22)
Effect of Pharmacogenomic Testing for Drug-Gene Interactions on Medication Selection and Remission of Symptoms in Major Depressive Disorder: The PRIME Care Randomized Clinical Trial. (2022) (22)
Genome‐wide association study of body mass index in subjects with alcohol dependence (2017) (22)
Sex-stratified gene-by-environment genome-wide interaction study of trauma, posttraumatic-stress, and suicidality (2021) (22)
Variation in the Nicotinic Acetylcholine Receptor Gene Cluster CHRNA5–CHRNA3–CHRNB4 and Its Interaction with Recent Tobacco Use Influence Cognitive Flexibility (2010) (22)
Deep resequencing of 17 glutamate system genes identifies rare variants in DISC1 and GRIN2B affecting risk of opioid dependence (2014) (21)
Adverse effects limit the usefulness of fluvoxamine for the treatment of alcoholism. (1993) (21)
Reductions in Alcohol Craving Following Naltrexone Treatment for Heavy Drinking. (2016) (21)
Effects of nicotine patch or nasal spray on nicotine and cotinine concentrations in pregnant smokers (2009) (21)
Association of COL25A1 with Comorbid Antisocial Personality Disorder and Substance Dependence (2012) (21)
Posttreatment effects of topiramate treatment for heavy drinking. (2014) (21)
AUDIT‐C and ICD codes as phenotypes for harmful alcohol use: association with ADH1B polymorphisms in two US populations (2018) (21)
Mutation screen of the glutamate decarboxylase‐67 gene and haplotype association to unipolar depression (2004) (20)
Effects of a diagnosis or family history of alcoholism on the taste intensity and hedonic value of sucrose. (2009) (20)
Medications for alcohol dependence--new vistas. (2000) (20)
Overview of Treatment Modalities for Dual-Diagnosis Patients: Pharmacotherapy, Psychotherapy, and 12-Step Programs (2004) (20)
GENETIC STUDY: Tryptophan hydroxylase 2 gene and alcohol use among college students (2008) (20)
GENETIC STUDY: Analysis of variations in the tryptophan hydroxylase‐2 (TPH2) gene in cocaine dependence (2006) (20)
Shared Genetic Risk between Eating Disorder- and Substance-Use-Related Phenotypes: Evidence from Genome-Wide Association Studies (2019) (20)
Genome‐wide association meta‐analysis of age at first cannabis use (2018) (19)
Stage of Change as a Predictor of Abstinence Among Alcohol-Dependent Subjects in Pharmacotherapy Trials. (1998) (19)
ADH7 variation modulates extraversion and conscientiousness in substance‐dependent subjects (2008) (19)
Pharmacogenetics of alcohol use disorder treatments: an update (2019) (19)
ANKRD7 and CYTL1 are novel risk genes for alcohol drinking behavior. (2012) (19)
Advances in the pharmacotherapy of alcoholism: challenging misconceptions. (2006) (19)
Variation in Mu-Opioid Receptor Gene (OPRM1) as a Moderator of Naltrexone Treatment to Reduce Heavy Drinking in a High Functioning Cohort. (2013) (19)
Subgroup Identification in Personalized Treatment of Alcohol Dependence. (2015) (19)
Interpopulation linkage disequilibrium patterns of GABRA2 and GABRG1 genes at the GABA cluster locus on human chromosome 4. (2008) (19)
Examining the effects of alcohol on GABAA receptor mRNA expression and function in neural cultures generated from control and alcohol dependent donor induced pluripotent stem cells. (2018) (19)
Salivary microRNAs identified by small RNA sequencing and machine learning as potential biomarkers of alcohol dependence. (2019) (19)
Systematic Review and Meta-Analysis of the Moderating Effect of rs1799971 in OPRM1, the Mu-opioid Receptor Gene, on Response to Naltrexone Treatment of Alcohol Use Disorder. (2020) (19)
The Effect of Cigarette Smoking on Fetal Heart Rate Characteristics (2002) (19)
Headaches and Psychoactive Substance Use (1991) (18)
Issues in the definition and diagnosis of alcoholism: Implications for a reformulation (1986) (18)
Identification of population substructure among Jews using STR markers and dependence on reference populations included (2010) (18)
Efficacy and Tolerability of Long-Acting Injectable Naltrexone for Alcohol DependenceA Randomized Controlled Trial (2005) (18)
Molecular genetic overlap between posttraumatic stress disorder and sleep phenotypes. (2019) (18)
Reduction in non-abstinent World Health Organization (WHO) drinking risk levels and drug use disorders: 3-year follow-up results in the US general population. (2019) (18)
Association study of personality factors and the Asn40Asp polymorphism at the μ-opioid receptor gene (OPRM1) (2004) (18)
Variation in regulator of G-protein signaling 17 gene (RGS17) is associated with multiple substance dependence diagnoses (2012) (17)
FKBP5 variation is associated with the acute and chronic effects of nicotine (2014) (17)
Brief motivational enhancement and coping skills interventions for heavy drinking. (2007) (17)
Association study of DTNBP1 with schizophrenia in a US sample (2009) (17)
Determination of fluvoxamine concentration in plasma by reversed-phase liquid chromatography. (1994) (17)
Exploring the genetic architecture of alcohol dependence in African-Americans via analysis of a genomewide set of common variants (2014) (17)
A genome-wide association study of cocaine use disorder accounting for phenotypic heterogeneity and gene–environment interaction (2019) (17)
Buspirone treatment of anxiety in a patient dependent on alprazolam. (1989) (17)
Genetic underpinnings of risky behaviour relate to altered neuroanatomy (2019) (17)
5‐HTTLPR genotype and daily negative mood moderate the effects of sertraline on drinking intensity (2013) (17)
ADH1A variation predisposes to personality traits and substance dependence (2010) (17)
Genetic factor common to schizophrenia and HIV infection is associated with risky sexual behavior: antagonistic vs. synergistic pleiotropic SNPs enriched for distinctly different biological functions (2016) (16)
Ordered subset linkage analysis based on admixture proportion identifies new linkage evidence for alcohol dependence in African-Americans (2013) (16)
Alcohol and nicotine codependence-associated DNA methylation changes in promoter regions of addiction-related genes (2017) (16)
Variation in OPRM1 and risk of suicidal behavior in drug-dependent individuals. (2012) (16)
Nf1 Regulates Alcohol Dependence-Associated Excessive Drinking and Gamma-Aminobutyric Acid Release in the Central Amygdala in Mice and Is Associated with Alcohol Dependence in Humans (2015) (16)
Post-GWAS analysis of six substance use traits improves the identification and functional interpretation of genetic risk loci. (2019) (16)
Ancestry‐specific and sex‐specific risk alleles identified in a genome‐wide gene‐by‐alcohol dependence interaction study of risky sexual behaviors (2017) (16)
Identification of POMC Exonic Variants Associated with Substance Dependence and Body Mass Index (2012) (16)
Translational studies support a role for serotonin 2B receptor (HTR2B) gene in aggression-related cannabis response (2018) (15)
Variants in the α2A AR adrenergic receptor gene in psychiatric patients (1998) (15)
Author Correction: Genome-wide association study of alcohol consumption and use disorder in 274,424 individuals from multiple populations (2019) (15)
Nogo 3'-untranslated region CAA insertion: failure to replicate association with schizophrenia and demonstration of marked population difference in frequency of the insertion. (2004) (15)
Which alcohol use disorder criteria contribute to the association of ADH1B with alcohol dependence? (2016) (15)
Transancestral GWAS of alcohol dependence reveals common genetic underpinnings with psychiatric disorders (2018) (15)
Urgency traits moderate daily relations between affect and drinking to intoxication among young adults. (2017) (15)
Validating Harmful Alcohol Use as a Phenotype for Genetic Discovery Using Phosphatidylethanol and a Polymorphism in ADH1B (2017) (15)
Genome-Wide Association Study of Opioid Cessation (2020) (15)
Examining FKBP5 mRNA expression in human iPSC-derived neural cells (2017) (15)
Autosomal linkage scan for loci predisposing to comorbid dependence on multiple substances (2012) (14)
Multi-environment gene interactions linked to the interplay between polysubstance dependence and suicidality (2021) (14)
Mental Disorders; Alcohol- and Drug-Related Problems: International Perspectives on Their Diagnosis and Classification (1988) (13)
Alcohol-responsive genes identified in human iPSC-derived neural cultures (2018) (13)
Salty and sour taste characteristics and risk of alcoholism. (2003) (13)
CALCYON gene variation, schizophrenia, and cocaine dependence (2004) (13)
Multi-trait genome-wide association study of opioid addiction: OPRM1 and beyond (2021) (13)
Memantine for Alcohol Dependence: An Open-label Pilot Study (2007) (13)
Confirmation and Generalization of an Alcohol-Dependence Locus on Chromosome 10q (2010) (13)
Meta-analysis of problematic alcohol use in 435,563 individuals identifies 29 risk variants and yields insights into biology, pleiotropy and causality (2019) (13)
Apolipoprotein E gene polymorphism, posttraumatic stress disorder, and cognitive function in older U.S. veterans: Results from the National Health and Resilience in Veterans Study (2019) (13)
Phenothiazine-associated lupus anticoagulant and thrombotic disease. (1988) (13)
Agitated depression in substance dependence. (2011) (13)
Multivariate genome-wide association meta-analysis of over 1 million subjects identifies loci underlying multiple substance use disorders (2022) (13)
Genome-wide association study in individuals of European and African ancestry and multi-trait analysis of opioid use disorder identifies 19 independent genome-wide significant risk loci (2022) (13)
Variation in AKR1C3, which encodes the neuroactive steroid synthetic enzyme 3α-HSD type 2 (17β-HSD type 5), moderates the subjective effects of alcohol (2014) (12)
Giving ethanol to alcoholics in a research setting: its effect on compliance with disulfiram treatment. (1990) (12)
Closing the gap between alcoholism research and practice: the case for pharmacotherapy. (1996) (12)
GABRA2 genotype, impulsivity, and body mass. (2012) (12)
Challenges to medications development in treating alcohol dependence: an international perspective. (2004) (12)
Randomized Trial of Nicotine Inhaler for Pregnant Smokers. (2019) (12)
Effects of naltrexone treatment for alcohol-related disorders on healthcare costs in an insured population. (2010) (12)
Enhancing Discovery of Genetic Variants for Posttraumatic Stress Disorder Through Integration of Quantitative Phenotypes and Trauma Exposure Information (2021) (12)
Utility of a brief cognitive screening instrument in substance abuse patients: initial investigation. (1991) (12)
Risk Locus Identification Ties Alcohol Withdrawal Symptoms to SORCS2 (2018) (12)
An in-frame deletion in the alpha(2C) adrenergic receptor is common in African--Americans. (2001) (12)
Patterns and Correlates of Prescription Opioid Receipt Among US Veterans: A National, 18-Year Observational Cohort Study (2019) (11)
Sex‐specific linkage scans in opioid dependence (2017) (11)
Effects of Prenatal Tobacco Exposure on Gene Expression Profiling in Umbilical Cord Tissue (2008) (11)
Patient Predictors of Irregular Discharge from Inpatient Substance Abuse Treatment (1994) (11)
Sources of unreliability in the diagnosis of substance dependence. (2009) (11)
A genome-wide association study for nonalcoholic fatty liver disease identifies novel genetic loci and trait-relevant candidate genes in the Million Veteran Program. (2021) (11)
GWAS including 82,707 subjects identifies functional coding variant in OPRM1 gene associated with opioid use disorder (2019) (11)
The α-endomannosidase gene (MANEA) is associated with panic disorder and social anxiety disorder (2014) (11)
An in-frame deletion in the α2C adrenergic receptor is common in African–Americans (2001) (11)
The effects of naltrexone on alcohol consumption and affect reactivity to daily interpersonal events among heavy drinkers. (2006) (11)
A revised allele frequency estimate and haplotype analysis of the DBH deficiency mutation IVS1+2T → C in African‐ and European‐Americans (2003) (11)
Cumulative proportion of responders analysis (CPRA) as a tool to assess treatment outcome in alcohol clinical trials. (2014) (11)
Genome-wide association study identifies glutamate ionotropic receptor GRIA4 as a risk gene for comorbid nicotine dependence and major depression (2018) (11)
S100A10 identified in a genome-wide gene × cannabis dependence interaction analysis of risky sexual behaviours (2017) (10)
The World Health Organization Risk Drinking Levels Measure of Alcohol Consumption: Prevalence and Health Correlates in Nationally Representative Surveys of U.S. Adults, 2001-2002 and 2012-2013. (2021) (10)
Using phenotype risk scores to enhance gene discovery for generalized anxiety disorder and posttraumatic stress disorder (2022) (10)
Drinking Goals and Attainment in a Naltrexone Trial of Young Adult Heavy Drinkers (2018) (10)
A protocadherin gene cluster regulatory variant is associated with nicotine withdrawal and the urge to smoke (2017) (10)
Trauma exposure interacts with the genetic risk of bipolar disorder in alcohol misuse of US soldiers (2018) (10)
Variation in NGFB is associated with primary affective disorders in women (2011) (10)
Alcohol and drug abuse treatment at the University of Connecticut Health Center. (1992) (10)
ACSL6 Is Associated with the Number of Cigarettes Smoked and Its Expression Is Altered by Chronic Nicotine Exposure (2011) (9)
Genome-Wide Meta-Analyses of FTND and TTFC Phenotypes. (2019) (9)
Opioid Misuse as a Predictor of Alcohol Treatment Outcomes in the COMBINE Study: Mediation by Medication Adherence (2018) (9)
Validating a non-invasive, ALT-based non-alcoholic fatty liver phenotype in the million veteran program (2020) (9)
Topiramate versus naltrexone for alcohol use disorder: study protocol for a genotype-stratified, double-blind randomised controlled trial (TOP study) (2018) (9)
Variants in the alpha2A AR adrenergic receptor gene in psychiatric patients. (1998) (9)
Balancing risk and benefit in heavy drinkers treated with topiramate: implications for personalized care. (2016) (9)
Opioid Use and Rate of Nicotine Metabolism among Pregnant Smokers. (2019) (9)
Genomewide Gene-by-Sex Interaction Scans Identify ADGRV1 for Sex Differences in Opioid Dependent African Americans (2019) (9)
Major depression and PTSD in pregnant smokers enrolled in nicotine gum treatment trial. (2013) (9)
Multi-view biclustering for genotype-phenotype association studies of complex diseases (2013) (9)
Effects of LY466195, a selective kainate receptor antagonist, on ethanol preference and drinking in rats (2017) (9)
What happens when people discontinue taking medications? Lessons from COMBINE. (2014) (9)
Eye color: A potential indicator of alcohol dependence risk in European Americans (2015) (8)
Daily relations among affect, urge, targeted naltrexone, and alcohol use in young adults. (2016) (8)
Population admixture modulates risk for alcohol dependence (2009) (8)
Using DNA methylation to validate an electronic medical record phenotype for smoking (2018) (8)
Reduction in World Health Organization Risk Drinking Levels and Cardiovascular Disease. (2020) (8)
Genome‐wide scan identifies opioid overdose risk locus close to MCOLN1 (2020) (8)
Alcoholism: clinical implications of recent research. (1988) (8)
Recessive genetic mode of an ADH4 variant in substance dependence in African-Americans: A model of utility of the HWD test (2008) (8)
Substance use disorders in patients with chronic fatigue. (1991) (8)
Cross-ancestry meta-analysis of opioid use disorder uncovers novel loci with predominant effects on brain (2021) (8)
Survey of Addiction Specialists’ Use of Medications to Treat Alcohol Use Disorder (2020) (8)
A double-blind comparison of abecarnil and diazepam in the treatment of uncomplicated alcohol withdrawal (1997) (8)
A Delta-Opioid Receptor Gene Polymorphism Moderates the Therapeutic Response to Extended-Release Buprenorphine in Opioid Use Disorder (2020) (8)
Stage of Change as a Predictor of Abstinence Among Alcohol-Dependent Subjects in Pharmacotherapy Trials (1998) (8)
Differentiating Types of Self-Reported Alcohol Abstinence (2019) (8)
Phenome-wide Association Analysis of Substance Use Disorders in a Deeply Phenotyped Sample (2022) (8)
Critical evaluation of transcription factor Atf2 as a candidate modulator of alcohol preference in mouse and human populations. (2013) (7)
Longitudinal findings from a randomized clinical trial of naltrexone for young adult heavy drinkers. (2016) (7)
An analysis of the effect of mu-opioid receptor gene (OPRM1) promoter region DNA methylation on the response of naltrexone treatment of alcohol dependence (2020) (7)
Incentive program decreases no-shows in nontreatment substance abuse research. (2005) (7)
Analysis of extreme drinking in patients with alcohol dependence using Pareto regression (2010) (7)
Clinical Manual of Addiction Psychopharmacology (2013) (7)
Should the reorganization of addiction-related research across all the National Institutes of Health be structural?--The devil is truly in the details. (2011) (7)
Ttn as a likely causal gene for QTL of alcohol preference on mouse chromosome 2 (2014) (7)
Stability of Drinking Reductions and Long-term Functioning Among Patients with Alcohol Use Disorder (2020) (7)
Genetics of Addiction (2014) (7)
Cross-ancestry meta-analysis of opioid use disorder uncovers novel loci with predominant effects in brain regions associated with addiction (2022) (6)
Study design and implementation of the PRecision Medicine In MEntal health Care (PRIME Care) Trial. (2020) (6)
Genome-wide association study and multi-trait analysis of opioid use disorder identifies novel associations in 639,709 individuals of European and African ancestry. (2021) (6)
Sequence variation and linkage disequilibrium in the GABA transporter-1 gene (SLC6A1) in five populations: implications for pharmacogenetic research (2007) (6)
Topiramate's reduction of body mass index in heavy drinkers: lack of moderation by a GRIK1 polymorphism. (2014) (6)
Self-Efficacy as a Predictor of Relapse During Treatment for Alcohol Dependence (2003) (6)
Comorbidity of personality disorders and substance use disorders (2004) (6)
Evaluating the role of a galanin enhancer genotype on a range of metabolic, depressive and addictive phenotypes (2014) (6)
Refining multivariate disease phenotypes for high chip heritability (2015) (6)
Genome-wide association study of phenotypes measuring progression from first cocaine or opioid use to dependence reveals novel risk genes. (2021) (6)
Atypical Koro (1988) (6)
GRIK1 genotype and daily expectations of alcohol's positive effects moderate the reduction of heavy drinking by topiramate. (2014) (6)
Characteristics and course of dependence in cocaine-dependent individuals who never used alcohol or marijuana or used cocaine first. (2014) (6)
Translating the semi-structured assessment for drug dependence and alcoholism in the Western Pacific: rationale, study design and reliability of alcohol dependence. (2014) (6)
The phenomics and genetics of addictive and affective comorbidity in opioid use disorder. (2021) (6)
The Impact of Removing Former Drinkers from Genome-wide Association Studies of AUDIT-C. (2021) (5)
Genetic underpinnings of the transition from alcohol consumption to alcohol use disorder: shared and unique genetic architectures in a cross-ancestry sample (2021) (5)
An Effective Method to Identify Heritable Components from Multivariate Phenotypes (2015) (5)
Panel Session (2022) (5)
Multimodal brain imaging study of 36,678 participants reveals adverse effects of moderate drinking (2020) (5)
Reward drinking and naltrexone treatment response among young adult heavy drinkers. (2021) (5)
Quadratic optimization to identify highly heritable quantitative traits from complex phenotypic features (2013) (5)
Psychosocial Issues Concerning a Pregnant Adolescent with Hodgkin's Disease (1987) (5)
Genetic liability for substance use associated with medical comorbidities in electronic health records of African‐ and European‐ancestry individuals (2021) (5)
A laboratory procedure for evaluation of pharmacotherapy for cocaine dependence. (1989) (5)
Fluvoxamine is Poorly Tolerated by Alcoholics (1992) (5)
Psychological trauma and the genetic overlap between posttraumatic stress disorder and major depressive disorder (2020) (5)
Prospective randomized pharmacogenetic study of topiramate for treating alcohol use disorder (2021) (5)
Effects of Recent Alcohol Consumption Level on Neurocognitive Performance in HIV+ Individuals (2017) (5)
Effects of topiramate on neural responses to alcohol cues in treatment-seeking individuals with alcohol use disorder: preliminary findings from a randomized, placebo-controlled trial (2021) (5)
World Health Organization Risk Drinking Levels as a Treatment Outcome Measure in Topiramate Trials. (2021) (5)
Nutritional Ketosis as a Potential Treatment for Alcohol Use Disorder (2021) (5)
Reliability and validity of DSM-IV and DSM-5 methamphetamine use disorder diagnoses using the Chinese Version of the Semi-Structured Assessment for Drug Dependence and Alcoholism (SSADDA). (2021) (4)
5-HTTLPR moderates naltrexone and psychosocial treatment responses in heavy drinking men who have sex with men. (2014) (4)
Sodium chloride treatment of antidepressant-induced orthostatic hypotension. (1988) (4)
Trauma and posttraumatic stress interact with sex-specific risk loci for suicidality and converge on brain extracellular matrix biology and synaptic plasticity (2020) (4)
The efficacy and safety of a fixed versus titrated dosage regimen of nicotine gum for smoking cessation or reduction in pregnancy (2006) (4)
Combined analysis of the moderating effect of a GRIK1 polymorphism on the effects of topiramate for treating alcohol use disorder. (2021) (4)
How Should Addiction-Related Research at the National Institutes of Health be Reorganized? (2011) (4)
Integrating human brain proteomic data with genome-wide association study findings identifies novel brain proteins in substance use traits (2022) (4)
Genome-Wide Investigation of Maximum Habitual Alcohol Intake in US Veterans in Relation to Alcohol Consumption Traits and Alcohol Use Disorder (2022) (4)
Genome‐wide association study of cognitive flexibility assessed by the Wisconsin Card Sorting Test (2018) (4)
Pregnant Smokers Receiving Opioid Agonist Therapy Have an Elevated Nicotine Metabolite Ratio: A Replication Study (2020) (4)
ODACH: a one-shot distributed algorithm for Cox model with heterogeneous multi-center data (2021) (4)
Multiview Comodeling to Improve Subtyping and Genetic Association of Complex Diseases (2014) (4)
Smoking and Cellular Telephone Use Among Pregnant Women Seeking Prenatal Care: Opportunities for Intervention (2015) (4)
How to measure relapse in humans (2005) (4)
The Pharmacology of Alcohol Abuse: An Introduction (1995) (4)
A genome-wide gene-by-trauma interaction study of alcohol misuse in two independent cohorts identifies PRKG 1 as a risk locus (2017) (4)
Identifying and Reducing Bias in Genome-Wide Association Studies of Alcohol-Related Traits. (2022) (4)
Longitudinal Drinking Patterns and Their Clinical Correlates in Million Veteran Program Participants (2019) (4)
Identifying Clinical Risk Factors for Opioid Use Disorder using a Distributed Algorithm to Combine Real-World Data from a Large Clinical Data Research Network (2020) (4)
Response to Dr. Kopke's comments on haplotypes at the OPRM1 locus (2005) (3)
A multi-objective program for quantitative subtyping of clinically relevant phenotypes (2012) (3)
Long-term use of hydrocodone vs. oxycodone in primary care. (2019) (3)
Commentary on Garbutt et al. (2014): Can we predict who benefits from naltrexone in the treatment of alcohol dependence? (2014) (3)
Genome-wide meta-analysis of alcohol use disorder in East Asians (2021) (3)
Correction: ACSL6 Is Associated with the Number of Cigarettes Smoked and Its Expression Is Altered by Chronic Nicotine Exposure (2012) (3)
Investigation of convergent and divergent genetic influences underlying schizophrenia and alcohol use disorder (2021) (3)
Prevalence of predicted gene-drug interactions for antidepressants in the treatment of major depressive disorder in the Precision Medicine in Mental Health Care Study. (2021) (3)
Persistent Urinary Benzoylecgonine Following Cocaine Use (1992) (3)
Is the medication bottle half full or half empty (1997) (3)
Accuracy of Consumer-marketed smartphone-paired alcohol breath testing devices: A laboratory validation study. (2021) (3)
Ancestry May Confound Genetic Machine Learning: Candidate-Gene Prediction of Opioid Use Disorder as an Example (2020) (3)
A case of infant botulism in New England. (1984) (3)
Genetic Data Can Lead to Medical Discrimination: Cautionary tale of Opioid Use Disorder (2020) (3)
PMH13 CHARACTERISTICS AND COST OUTCOMES OF INSURED PATIENTS TREATED WITH EXTENDED-RELEASE NALTREXONE (XR-NTX) OR ORAL ALCOHOL DEPENDENCE MEDICATIONS (2010) (2)
Medications to treat heavy drinking: are we there yet? (2006) (2)
GABRA 2 Genotype , Impulsivity , and Body Mass (2019) (2)
Ancestry may confound genetic machine learning: Candidate-gene prediction of opioid use disorder as an example. (2021) (2)
Author Correction: Genomewide Study of Epigenetic Biomarkers of Opioid Dependence in European- American Women (2019) (2)
The Identification and Treatment of Alcohol Abuse and Dependency (1990) (2)
Placebo-Controlled Trial of Bupropion for Smoking Cessation in Pregnant Women. (2021) (2)
Circadian Pattern of Deaths Due to Suicide in Intoxicated Alcohol-Dependent Individuals. (2018) (2)
Medications for use in alcohol rehabilitation (2014) (2)
A regulatory variant of CHRM3 is associated with cannabis-induced hallucinations in European Americans (2019) (2)
Extended-Release Intramuscular Naltrexone (2012) (2)
Pharmacotherapies for Alcoholism: Theoretical and Methodological Perspectives (1995) (2)
Examining a brief measure and observed cutoff scores to identify reward and relief drinking profiles: Psychometric properties and pharmacotherapy response. (2021) (2)
Epigenomic profiles of African American Transthyretin Val122Ile carriers reveals putatively dysregulated amyloid mechanisms (2020) (2)
Diagnostic Reliability and Validity of the Semi-Structured Assessment for Drug Dependence and Alcoholism (SSADDA) Chinese Version (2020) (2)
Post‐treatment effects of topiramate on alcohol‐related outcomes: A combined analysis of two placebo‐controlled trials (2022) (2)
The Relationship of Attention-Deficit/Hyperactivity Disorder With Posttraumatic Stress Disorder: A Two-Sample Mendelian Randomization and Population-Based Sibling Comparison Study (2022) (2)
Can We Predict Who Benefits from Naltrexone in the Treatment of Alcohol Dependence? (2014) (2)
Further analyses support the association between light eye color and alcohol dependence (2015) (2)
Is it time to rethink low-risk drinking guidelines? (2022) (1)
GWAS and network analysis of co‐occurring nicotine and alcohol dependence identifies significantly associated alleles and network (2018) (1)
An Intensive Longitudinal Examination of Topiramate Treatment for Alcohol Use Disorder: A Secondary Analysis of Data from a Randomized Controlled Trial. (2023) (1)
Predictors of Treatment Referral After AUDIT-C Screening for Heavy Drinking (2018) (1)
Letter to the Editor: Non-Drug Addictive Disorders in Cocaine-Dependent Subjects—A Response to Merlo et al. (2008) (1)
Complex multi-environment gene interactions linked to the interplay between polysubstance dependence and suicidal behaviors (2020) (1)
FUNCTIONAL CODING VARIANT IN OPRM1 GENE ASSOCIATED WITH OPIOID USE DISORDER: EVIDENCE FROM GWAS ON LARGE COHORTS (2019) (1)
908. Genome-Wide Association Study Identifies HTR2B as a Risk Variant of Cannabis-Related Aggression in African Americans (2017) (1)
Molecular correlates of topiramate and GRIK1 rs2832407 genotype in pluripotent stem cell-derived neural cultures (2019) (1)
Within- and between-person effects of naltrexone on subjective response to alcohol and craving: A daily diary investigation. (2022) (1)
PM296. SORCS2 regulates alcohol withdrawal severity and excitatory synaptic transmission (2016) (1)
F123. Genome-Wide Epigenetic Signatures of Major Depressive Disorder in Women (2018) (1)
Variation in regulator of G-protein signaling 17 gene (RGS17) is associated with multiple substance dependence diagnoses (2012) (1)
The first clinical year of medical school. (1984) (1)
Factors associated with opioid cessation: a machine learning approach (2019) (1)
Identification of Novel, Replicable Genetic Risk Loci for Suicidal Thoughts and Behaviors Among US Military Veterans. (2022) (1)
Scale for Assessment of Positive Symptoms for Cocaine-Induced Psychosis (2014) (1)
Complex Multi-Environment Gene Interactions at the Basis of the Interplay Between Polysubstance Abuse and Suicide Behaviors (2020) (1)
Alcohol withdrawal in past-year drinkers with unhealthy alcohol use: Prevalence, characteristics, and correlates in a national epidemiologic survey. (2022) (1)
Using 18F-NOS PET Imaging to Measure Pulmonary Inflammation in Electronic and Combustible Cigarette Users: A Pilot Study (2022) (1)
Treating Alcohol Use Disorder With Hallucinogens-Renewed Interest After a 50-Year Hiatus. (2022) (1)
Current Perspectives in Cultural Psychiatry. E. F. Foulks, R. M. Wintrob, J. Westermeyer and A. R. Favazza, eds (1981) (1)
Topiramate as Treatment for Alcohol Dependence—Reply (2008) (1)
Extended-release intramuscular naltrexone: a viewpoint by Henry R Kranzler. (2006) (1)
Multi-trait Analysis of GWAS (MTAG) of Substance Use Traits Identifies Novel Genetic Loci and Phenomic Associations (2022) (1)
Exploring the genetic architecture of alcohol dependence in African-Americans via analysis of a genomewide set of common variants (2013) (1)
Genome-wide association study of stimulant dependence (2021) (1)
Ttn as a likely causal gene for QTL of alcohol preference on mouse chromosome 2 (2014) (1)
Multi-view singular value decomposition for disease subtyping and genetic associations (2014) (1)
Analysis of genetic and clinical factors associated with buprenorphine response. (2021) (1)
New Initiatives for Alcoholism: Clinical and Experimental Research. (2016) (1)
Endorsement of the CONSORT Principles in Reporting Alcohol Clinical Trials in ACER. (2015) (1)
Genome-wide investigation of maximum habitual alcohol intake (MaxAlc) in 247,755 European and African Ancestry U.S. Veterans informs the relationship between habitual alcohol consumption and alcohol use disorder. (2022) (1)
Identifying factors associated with opioid cessation in a biracial sample using machine learning (2020) (1)
Genome-wide Association Study of Alcohol Consumption and Use Disorder in Multiple Populations (N = 274,424) (2019) (1)
Author Correction: Genome-wide association study of alcohol consumption and use disorder in 274,424 individuals from multiple populations (2019) (1)
Antagonism of GluK1-containing kainate receptors reduces ethanol consumption by modulating ethanol reward and withdrawal (2021) (1)
Intragastric Infusion of Ethanol by Alcoholics After Surgery for Head and Neck Cancer (1992) (1)
Collaborative phenotype inference from comorbid substance use disorders and genotypes (2017) (1)
No allelic association of an exon 13 polymorphism of the Gsα gene to alcohol and/or drug dependence (1997) (1)
Differential Methylation and Co-Methylation Analysis Reveals Functional Targets of Major Depressive Disorder in Women (2021) (0)
Association of Topiramate Prescribed for any Indication with Reduced Alcohol Consumption in Electronic Health Record Data (2022) (0)
Increased ventral striatum activation in response to heroin cues in heroin-dependent women after extended-release naltrexone injection (2015) (0)
Speaker 3: Sachio Matsushita, Japan (2016) (0)
71. GENOME-WIDE INVESTIGATION OF MAXIMUM HABITUAL ALCOHOL INTAKE IN 258,545 MVP EUROPEAN AND AFRICAN ANCESTRY U.S. VETERANS (2021) (0)
Genetics of Substance Dependence (2007) (0)
41 EXPLORING THE ROLE OF GENETIC REGULATION OF GENE EXPRESSION IN SUBSTANCE USE AND DEPENDENCE (2019) (0)
Refining multivariate disease phenotypes for high chip heritability (2015) (0)
Polygenic Risk for Substance-Related Traits Predicts Substance Use Onset and Progression: Sex and Population Group Differences (2022) (0)
Genome-wide meta-analysis of problematic alcohol use in 435,563 individuals yields insights into biology and relationships with other traits (2020) (0)
C.11.03 Persistence in treatment, importance of treatment adherence and continued care (2015) (0)
M31 GENOME-WIDE ASSOCIATION STUDY OF COMORBID ALCOHOL DEPENDENCE AND MAJOR DEPRESSION (2019) (0)
The genetic architecture of pain intensity in a sample of 598,339 U.S. veterans (2023) (0)
Peripheral and Central Iron Measures in Alcohol Use Disorder and Aging: A Quantitative Susceptibility Mapping Pilot Study (2023) (0)
Policy changes for Alcoholism: Clinical and Experimental Research (ACER). (2021) (0)
Speaker 1: Bruce Cuthbert, USA (2016) (0)
The effects of acute oral naltrexone pretreatment on the abuse potential of intranasal methamphetamine, and the relationship between reward/punishment sensitivity and methamphetamine’s effects (2022) (0)
Topiramate and Heavy Drinking: Implications for Personalized Medicine (2014) (0)
MEDIATION ANALYSIS OF ALCOHOL USE DISORDER AND ALCOHOL CONSUMPTION REVEALS BOTH SHARED AND UNIQUE GENETIC ARCHITECTURE (2019) (0)
gitated depression in substance dependence dam (2011) (0)
A putative causal relationship between genetically determined female body shape and posttraumatic stress disorder (2017) (0)
Association of the OPRM1 Variant rs1799971 (A118G) with Non-Specific Liability to Substance Dependence in a Collaborative de novo Meta-Analysis of European-Ancestry Cohorts (2015) (0)
ISBN 0-8247-9895-3 THE DUALLY DIAGNOSED-A therapist ' s guide to helping the substance abusing , psychologically disturbed patient (2009) (0)
67. ADVANCED GENETIC STUDY OF PROBLEMATIC ALCOHOL USE IN MULTIPLE POPULATIONS IN > 1 MILLION SUBJECTS (2021) (0)
Effects of topiramate therapy on serum bicarbonate concentration in a sample of 10,279 veterans. (2023) (0)
SU137DIFFERENCES DETWEEN AUDIT-C AND AUD PHENOTYPES REVEALED BY GENOME-WIDE ANALYSIS (2019) (0)
Induced pluripotent stem cell reprogramming‐associated methylation at the GABRA2 promoter and chr4p12 GABAA subunit gene expression in the context of alcohol use disorder (2020) (0)
Author Correction: Genome-wide association study of alcohol consumption and use disorder in 274,424 individuals from multiple populations (2019) (0)
Use of a cue exposure paradigm for the evaluation of a potential pharmacotherapeutic agents for cocaine dependence. (1993) (0)
Multi-ancestry meta-analysis of tobacco use disorders based on electronic health record data prioritizes novel candidate risk genes and reveals associations with numerous health outcomes (2023) (0)
Identifying heritable composite traits from multivariate phenotypes and genome-wide SNPs (2014) (0)
3. Genetic Overlap and Causal Relationship Between Multisite Chronic Pain and Substance Use Disorders (2023) (0)
A randomized, double-blind, placebo-controlled, pharmacogenetic study of ondansetron for treating alcohol use disorder. (2022) (0)
Advanced Genetic Study of Problematic Alcohol Use in > 1 Million Subjects From Multiple Populations (2022) (0)
Genetics of Alcohol Use Disorder and Precision Pharmacotherapy (2023) (0)
Multi-trait genome-wide association analyses leveraging alcohol use disorder findings identify novel loci for smoking behaviors in the Million Veteran Program (2022) (0)
Molecular Imaging of Pulmonary Inflammation in Users of Electronic and Combustible Cigarettes: A Pilot Study (2023) (0)
Unique and joint associations of polygenic risk for major depression and opioid use disorder with endogenous opioid system function (2022) (0)
Tonic-clonic seizures with maprotiline. (1985) (0)
17. DIFFERENCES IN PHENOTYPIC ASSOCIATIONS OF GENETIC LIABILITY FOR SUBSTANCE USE BY ANCESTRY AND SEX (2021) (0)
Use of Medications to Treat Alcohol Use Disorder Survey (2020) (0)
Utility of the Cognitive Status Examination (CSE) for detection of neuropsychological impairment in substance abuse patients. (1990) (0)
Multisite learning of high-dimensional heterogeneous data with applications to opioid use disorder study of 15,000 patients across 5 clinical sites (2022) (0)
Does Polygenic Risk for Substance-Related Traits Predict Ages of Onset and Progression of Symptoms? (2023) (0)
Interstitial cellular components in the kidney of man and other vertebrates. (1983) (0)
Polygenic risk score for problematic alcohol use predicts heavy drinking and alcohol use disorder symptoms in young adulthood after accounting for adolescent alcohol use and parental alcohol use disorder (2023) (0)
Racial and Ethnic Bias in the Diagnosis of Alcohol Use Disorder in Veterans. (2023) (0)
The effects of alcohol on neurotransmitters appear to mediate the risk for alcohol use disorder : a brief update (2017) (0)
48. GENOME-WIDE ASSOCIATION STUDY OF ALCOHOL CONSUMPTION IDENTIFIES NOVEL LOCI IN LATIN AMERICAN POPULATIONS: FINDINGS FROM THE LATIN AMERICAN GENOMICS CONSORTIUM (2022) (0)
Effects of bromocriptine on subjective and autonomic responses to cocaine-associated stimuli. (1990) (0)
Pharmacogenetics of Psychotropic Drugs: Genetic variation and drug dependence risk factors (2002) (0)
Comparison of Healthcare Utilization among Patients Treated with Alcohol Dependence Medications (2010) (0)
Abstract 357: DNA Methylation Profiles of African American Val122Ile-Transthyretin Mutation Carriers Reveals Genes Involved in Amyloidosis Regulation (2020) (0)
Book Review: Clinical Manual of Addiction: Psychopharmacology (2006) (0)
Ms. Sandstrom and Dr. Kranzler Reply (2002) (0)
Identification of methylation quantitative trait loci (mQTLs) influencing promoter DNA methylation of alcohol dependence risk genes (2014) (0)
Boswell's affective illness: a reappraisal. (1989) (0)
Dr. Kranzler and Colleagues Reply (1998) (0)
Speaker 4: Joel Gelernter, USA (2016) (0)
COMORBID-PHENOME PREDICTION AND PHENOTYPE RISK SCORES INCREASE DATA AVAILABILITY FOR ANXIETY AND PTSD GENE DISCOVERY (2021) (0)
Author Correction: Genomewide Study of Epigenetic Biomarkers of Opioid Dependence in European- American Women (2019) (0)
F140PHARMACOEPIGENETICS OF ALCOHOL DEPENDENCE: NO SIGNIFICANT EFFECT OF MU-OPIOID RECEPTOR GENE (OPRM1) PROMOTER METHYLATION ON NALTREXONE TREATMENT RESPONSE (2019) (0)
Correction to: Prospective randomized pharmacogenetic study of topiramate for treating alcohol use disorder (2021) (0)
Precision Medicine and Pharmacogenetics: What Does Oncology Have that Addiction Medicine Doesn’t? (2017) (0)
Novel digital approaches to the assessment of problematic opioid use (2022) (0)
Racial Inequalities in Alcohol Use Disorder Diagnosis in a Sample of 700,000 Veterans (2021) (0)
F135GENOMEWIDE SEX-BY-SNP INTERACTION SCAN IDENTIFIES ADGRV1 FOR THE SEX DIFFERENCES OF OPIOID DEPENDENCE IN AFRICAN AMERICAN AND SUPPORTING EVIDENCE IN RELATIONS WITH TREATMENT SIDE EFFECTS IN THE ASIAN POPULATION (2019) (0)
Variation in AKR1C3, which encodes the neuroactive steroid synthetic enzyme 3α-HSD type 2 (17β-HSD type 5), moderates the subjective effects of alcohol (2014) (0)
Polysubstance addiction and psychiatric, somatic comorbidities among 7,989 individuals with cocaine use disorder: a latent class analysis (2023) (0)
to test elimination of alcohol craving and its potential con- sequences. (2017) (0)
PMH44 SURVEY AND STATED PREFERENCE TECHNIQUES FOR ESTIMATING THE DEMAND FOR ALCOHOLISM MEDICATIONS (2002) (0)
Inferring phenotypes from substance use via collaborative matrix completion (2018) (0)
Dutasteride reduces alcohol’s sedative effects in men in a human laboratory setting and reduces drinking in the natural environment (2014) (0)
A Meta-analysis of the Efficacy of Gabapentin for Treating AlcoholUse Disorder (2019) (0)
DSM-5 Gambling Disorder: (520662015-013) (2014) (0)
Naltrexone Treatment for Alcohol Dependency—Reply (2005) (0)
Evidence of shared genetic influences underlying schizophrenia and alcohol use disorder, but not alcohol consumption (2020) (0)
New and Revised Policies for Alcoholism: Clinical and Experimental Research (ACER). (2018) (0)
Novel digital approaches to the assessment of problematic opioid use (2022) (0)
F131. Genome-Wide Association Study Identifies Glutamate Ionotropic Receptor GRIA4 as a Risk Gene for Comorbid Nicotine Dependence and Major Depression (2018) (0)
Secondary depression: treatment and outcome. (1988) (0)
Ordered subset linkage analysis based on admixture proportion identifies new linkage evidence for alcohol dependence in African-Americans (2012) (0)
A genomewide ordered-subset linkage analysis for alcohol dependence in African-Americans (2010) (0)
T45 Genetic Factor Common To Schizophrenia And Hiv Infection Is Associated With Risky Sexual Behavior (2017) (0)
Alcohol use and alcohol use disorder differ in their genetic relationships with PTSD: A genomic structural equation modelling approach. (2022) (0)
Pharmacological Treatments for Heavy Drinking (2013) (0)
Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder (2018) (0)
Genetic factor common to schizophrenia and HIV infection is associated with risky sexual behavior: antagonistic vs. synergistic pleiotropic SNPs enriched for distinctly different biological functions (2016) (0)
The Relationship between Alcohol- and Sleep-related Traits: Results from Polygenic Risk Score Analyses and Mendelian Randomization Studies (2023) (0)
Initial Results From An Opioid Dependence Whole Exome Sequencing Study (2019) (0)
Comorbid-phenome prediction and phenotype risk scores enhance gene discovery for generalized anxiety disorder and posttraumatic stress disorder (2021) (0)
Announcing a name change for ACER. (2022) (0)
Associations between alcohol consumption and gray and white matter volumes in the UK Biobank (2022) (0)
Topiramate as Treatment for Alcohol Dependence. Authors' reply (2008) (0)
Title: Genes Influencing Cannabis Dependence Risk from GWAS (2016) (0)
Genetic Relationship between Schizophrenia and Nicotine Dependence (2016) (0)
Medications to Treat Alcohol Dependence : Adding to the Continuum of Care Related Letters (2007) (0)
68. CROSS-ANCESTRY META-ANALYSIS OF OPIOID USE DISORDER UNCOVERS NOVEL ASSOCIATED LOCI (2021) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Henry R. Kranzler?

Henry R. Kranzler is affiliated with the following schools:

Stanford University
University of Connecticut
University of Pennsylvania

Henry R. Kranzler's Academic­Influence.com Rankings

Henry R. Kranzler's Degrees

Why Is Henry R. Kranzler Influential?

Henry R. Kranzler's Published Works

Published Works

What Schools Are Affiliated With Henry R. Kranzler?

Henry R. Kranzler's AcademicInfluence.com Rankings